Genelux chief scientific officer sells $26,658 in stock

au.investing.com

Genelux Corp Chief Scientific Officer Yu Yong sold 9,683 shares of common stock on August 31, 2026, totaling $26,658 at a weighted average price of $2.7531 per share. The transaction was disclosed in a U.S. Securities and Exchange Commission filing. The sale was conducted to cover estimated taxes related to the vesting of restricted stock units. Following the transaction, Yu Yong directly owns 258,688 shares of Genelux common stock. GNLX shares have declined roughly 11% over the past week, trading at $2.55. Separately, Benchmark reiterated a Speculative Buy rating with a $20.00 price target, citing progress in the Olvi-Vec cancer immunotherapy trials.


With a significance score of 1, this news ranks in the top 67% of today's 33251 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Genelux chief scientific officer sells $26,658 in stock | News Minimalist